Stocks
Health Care
dmra
Damora Therapeutics
NASDAQ: DMRA
-0.22 (-0.76%)
28.69
USD
At close at Mar 20, 20:44 UTC
Overview
Loading chart...
Key Stats
Market Cap
38.08M
Dividend Yield
0.00%
P/E Ratio
-0.18
EPS
-18.67
Revenue
-
Avg. Volume
466.35K
Recently from Cashu
No Cashu articles
Damora Therapeutics currently has no Cashu-related articles
About
What does DMRA do?
Galecto, a Boston-based biotechnology company with 13 employees, focuses on developing small molecule therapeutics targeting cancer and fibrotic diseases, including GB0139 for Idiopathic Pulmonary Fibrosis. The company went public on October 29, 2020.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.